Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 41 | $118,549,403 |
| Sells | 16 | $2,675,457 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Feb 2025 17:14 | NMRA | Neumora Therapeutics Inc | BERNS PAUL L | See Remarks | 18 Feb 2025 | Sale | 13,871 | 1.6919 | 23,468 | D |
| 20 Feb 2025 17:14 | NMRA | Neumora Therapeutics Inc | MILLIGAN MICHAEL LEE | See Remarks | 18 Feb 2025 | Sale | 1,978 | 1.6939 | 3,351 | D |
| 20 Feb 2025 17:13 | NMRA | Neumora Therapeutics Inc | AURORA DALJIT SINGH | Chief Strategy Officer | 18 Feb 2025 | Sale | 8,565 | 1.6751 | 14,347 | D |
| 20 Feb 2025 17:12 | NMRA | Neumora Therapeutics Inc | LENZ ROBERT A. | Head of R&D | 18 Feb 2025 | Sale | 5,614 | 1.6714 | 9,383 | D |
| 20 Feb 2025 17:11 | NMRA | Neumora Therapeutics Inc | PINTO JOSHUA | President | 18 Feb 2025 | Sale | 8,048 | 1.6746 | 13,477 | D |
| 18 Oct 2024 18:25 | NMRA | Neumora Therapeutics Inc | FUST MATTHEW K | Director | 17 Oct 2024 | Sale | 7,739 | 17.0103 | 131,643 | D |
| 18 Oct 2024 18:25 | NMRA | Neumora Therapeutics Inc | FUST MATTHEW K | Director | 18 Oct 2024 | Sale | 14,049 | 17.0346 | 239,319 | D |
| 11 Oct 2024 16:10 | NMRA | Neumora Therapeutics Inc | LENZ ROBERT A. | Head of R&D | 09 Oct 2024 | Sale | 5,563 | 15.0112 | 83,507 | D |
| 11 Oct 2024 16:10 | NMRA | Neumora Therapeutics Inc | LENZ ROBERT A. | Head of R&D | 10 Oct 2024 | Sale | 8,260 | 15.0851 | 124,603 | D |
| 19 Sep 2024 16:35 | NMRA | Neumora Therapeutics Inc | LENZ ROBERT A. | Head of R&D | 18 Sep 2024 | Sale | 10,676 | 12.0917 | 129,091 | D |
| 19 Sep 2024 16:35 | NMRA | Neumora Therapeutics Inc | LENZ ROBERT A. | Head of R&D | 17 Sep 2024 | Sale | 30,788 | 11.8142 | 363,736 | D |
| 16 Sep 2024 16:05 | NMRA | Neumora Therapeutics Inc | LENZ ROBERT A. | Head of R&D | 12 Sep 2024 | Sale | 32,948 | 11.4321 | 376,665 | D |
| 27 Aug 2024 17:58 | NMRA | Neumora Therapeutics Inc | PINTO JOSHUA | Chief Financial Officer | 27 Aug 2024 | Sale | 15,693 | 11.394 | 178,806 | I |
| 26 Aug 2024 18:17 | NMRA | Neumora Therapeutics Inc | PINTO JOSHUA | Chief Financial Officer | 26 Aug 2024 | Sale | 31,642 | 11.7751 | 372,588 | I |
| 26 Aug 2024 18:17 | NMRA | Neumora Therapeutics Inc | PINTO JOSHUA | Chief Financial Officer | 23 Aug 2024 | Sale | 24,169 | 11.5853 | 280,005 | I |
| 26 Aug 2024 18:17 | NMRA | Neumora Therapeutics Inc | PINTO JOSHUA | Chief Financial Officer | 22 Aug 2024 | Sale | 28,496 | 11.6321 | 331,468 | I |
| 15 Nov 2023 18:55 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 14 Nov 2023 | Purchase | 3,357 | 11.98 | 40,217 | I |
| 15 Nov 2023 18:55 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 13 Nov 2023 | Purchase | 31,653 | 11.75 | 371,923 | I |
| 15 Nov 2023 18:54 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 14 Nov 2023 | Purchase | 3,357 | 11.98 | 40,217 | I |
| 15 Nov 2023 18:54 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 13 Nov 2023 | Purchase | 31,653 | 11.75 | 371,923 | I |
| 13 Nov 2023 19:01 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 10 Nov 2023 | Purchase | 5,431 | 11.75 | 63,814 | I |
| 13 Nov 2023 19:01 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 10 Nov 2023 | Purchase | 11,844 | 11.37 | 134,666 | I |
| 13 Nov 2023 19:01 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 08 Nov 2023 | Purchase | 23,124 | 11.79 | 272,632 | I |
| 13 Nov 2023 19:01 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 09 Nov 2023 | Purchase | 31,079 | 10.53 | 327,262 | I |
| 13 Nov 2023 19:01 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 08 Nov 2023 | Purchase | 69,127 | 10.78 | 745,189 | I |
| 13 Nov 2023 19:00 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 10 Nov 2023 | Purchase | 5,431 | 11.75 | 63,814 | I |
| 13 Nov 2023 19:00 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 09 Nov 2023 | Purchase | 31,079 | 10.53 | 327,262 | I |
| 13 Nov 2023 19:00 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 10 Nov 2023 | Purchase | 11,844 | 11.37 | 134,666 | I |
| 13 Nov 2023 19:00 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 08 Nov 2023 | Purchase | 23,124 | 11.79 | 272,632 | I |
| 13 Nov 2023 19:00 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 08 Nov 2023 | Purchase | 69,127 | 10.78 | 745,189 | I |
| 07 Nov 2023 19:00 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 07 Nov 2023 | Purchase | 30,192 | 11.5 | 347,208 | I |
| 07 Nov 2023 19:00 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 03 Nov 2023 | Purchase | 22,420 | 11.38 | 255,140 | I |
| 07 Nov 2023 19:00 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 06 Nov 2023 | Purchase | 43,082 | 11.55 | 497,597 | I |
| 07 Nov 2023 18:59 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 07 Nov 2023 | Purchase | 30,192 | 11.5 | 347,208 | I |
| 07 Nov 2023 18:59 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 06 Nov 2023 | Purchase | 43,082 | 11.55 | 497,597 | I |
| 07 Nov 2023 18:59 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 03 Nov 2023 | Purchase | 22,420 | 11.38 | 255,140 | I |
| 29 Sep 2023 18:55 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 29 Sep 2023 | Purchase | 34,560 | 13.98 | 483,149 | I |
| 29 Sep 2023 18:55 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 28 Sep 2023 | Purchase | 16,841 | 13.06 | 219,943 | I |
| 29 Sep 2023 18:55 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 28 Sep 2023 | Purchase | 25,110 | 13.69 | 343,756 | I |
| 29 Sep 2023 18:53 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 29 Sep 2023 | Purchase | 34,560 | 13.98 | 483,149 | I |
| 29 Sep 2023 18:53 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 28 Sep 2023 | Purchase | 25,110 | 13.69 | 343,756 | I |
| 29 Sep 2023 18:53 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 28 Sep 2023 | Purchase | 16,841 | 13.06 | 219,943 | I |
| 27 Sep 2023 20:19 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 27 Sep 2023 | Purchase | 24,504 | 12.31 | 301,644 | I |
| 27 Sep 2023 20:19 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 26 Sep 2023 | Purchase | 34,000 | 11.73 | 398,820 | I |
| 27 Sep 2023 20:18 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 27 Sep 2023 | Purchase | 24,504 | 12.31 | 301,644 | I |
| 27 Sep 2023 20:18 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 26 Sep 2023 | Purchase | 34,000 | 11.73 | 398,820 | I |
| 25 Sep 2023 21:38 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 25 Sep 2023 | Purchase | 29,967 | 11.65 | 349,116 | I |
| 25 Sep 2023 21:38 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 25 Sep 2023 | Purchase | 30,773 | 10.8 | 332,348 | I |
| 25 Sep 2023 21:38 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS XII, LLC | 10% | 22 Sep 2023 | Purchase | 40,000 | 11.14 | 445,600 | I |
| 25 Sep 2023 21:37 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 25 Sep 2023 | Purchase | 30,773 | 10.8 | 332,348 | I |
| 25 Sep 2023 21:37 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 25 Sep 2023 | Purchase | 29,967 | 11.65 | 349,116 | I |
| 25 Sep 2023 21:37 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 22 Sep 2023 | Purchase | 40,000 | 11.14 | 445,600 | I |
| 20 Sep 2023 06:23 | NMRA | Neumora Therapeutics Inc | BUROW KRISTINA | Director , 10% | 19 Sep 2023 | Purchase | 1,500,000 | 17 | 25,500,000 | I |
| 20 Sep 2023 06:16 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS X, LLC | 10% | 19 Sep 2023 | Purchase | 1,500,000 | 17 | 25,500,000 | I |
| 20 Sep 2023 06:15 | NMRA | Neumora Therapeutics Inc | ARCH VENTURE PARTNERS X, LLC | 10% | 19 Sep 2023 | Purchase | 1,500,000 | 17 | 25,500,000 | I |
| 19 Sep 2023 21:47 | NMRA | Neumora Therapeutics Inc | GOSEBRUCH HENRY O | President & CEO | 19 Sep 2023 | Purchase | 15,000 | 12.6247 | 189,370 | I |
| 19 Sep 2023 19:52 | NMRA | Neumora Therapeutics Inc | AMGEN INC | 10% | 19 Sep 2023 | Purchase | 1,764,705 | 17 | 29,999,985 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)